









市場行情
/
股票
/
nasdaq-cstl
/

Castle Biosciences Inc

CSTL

15.320USD

+0.670+4.57%

收盤 08/04, 16:00（美東）報價延遲15分鐘

441.90M總市值

虧損本益比TTM



Castle Biosciences Inc

15.320

+0.670+4.57%

概覽公司財務

Castle Biosciences, Inc. 是一家商業階段診斷公司。該公司專注於爲醫生及其患者提供個性化、臨牀可操作的信息，以便醫生及其患者做出治療決策並改善健康結果。其產品組合包括皮膚癌、葡萄膜黑色素瘤、巴雷特食管和精神健康狀況的檢測。其產品包括 DecisionDx-Melanoma、DecisionDx-SCC、MyPath Melanoma、TissueCypher 和 DecisionDx-UM、IDgenetix。DecisionDx-Melanoma 是一種風險分層基因表達譜 (GEP) 測試，可預測被診斷爲侵襲性皮膚黑色素瘤 (CM)（一種致命皮膚癌）的患者的轉移或復發風險。MyPath Melanoma 是針對難以診斷的黑色素細胞病變患者的 GEP 測試。 IDgenetix 是一種藥物基因組學 (PGx) 測試，有助於指導患有重度抑鬱症、躁鬱症等的患者進行最佳藥物治療。

公司簡介

公司代碼CSTL

公司名稱Castle Biosciences Inc

上市日期Jul 25, 2019

CEOMr. Derek J. Maetzold

員工數量761

證券類型Ordinary Share

年結日Jul 25

公司地址505 S Friendswood Drive

城市FRIENDSWOOD

上市交易所NASDAQ Global Market Consolidated

國家United States of America

郵編77546

電話18667889007

網址https://castlebiosciences.com/

公司代碼CSTL

上市日期Jul 25, 2019

CEOMr. Derek J. Maetzold

公司高階主管

名稱

名稱/職務

職務

持股

持股變動

Mr. Derek J. Maetzold

President, Chief Executive Officer, Founder, Director

361.91K

-1.35%

Ms. Kristen M. Oelschlager

Chief Operating Officer

163.96K

+7.62%

Mr. Tobin W. (Toby) Juvenal

Chief Commercial Officer

80.41K

+11.41%

Mr. Frank Stokes

Chief Financial Officer

43.33K

+22.68%

Ms. Ellen Goldberg

Independent Director

27.25K

+46.68%

Mr. Miles D. Harrison

Independent Director

21.96K

+65.25%

Mr. Rodney Cotton

Independent Director

19.33K

+81.38%

Ms. Tiffany P. Olson

Independent Director

Ms. Kimberlee S. Caple

Independent Director

Mr. Daniel Mark (Dan) Bradbury

Independent Chairman of the Board

名稱

名稱/職務

職務

持股

持股變動

Mr. Derek J. Maetzold

President, Chief Executive Officer, Founder, Director

361.91K

-1.35%

Ms. Kristen M. Oelschlager

Chief Operating Officer

163.96K

+7.62%

Mr. Tobin W. (Toby) Juvenal

Chief Commercial Officer

80.41K

+11.41%

Mr. Frank Stokes

Chief Financial Officer

43.33K

+22.68%

Ms. Ellen Goldberg

Independent Director

27.25K

+46.68%

Mr. Miles D. Harrison

Independent Director

21.96K

+65.25%

收入明細

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

暫無數據

地區USD

名稱

營收

佔比

United States

87.99M

0.00%

業務

地區

暫無數據

股東統計

更新時間: 7月27日週日

持股股東

股東類型

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

8.01%

The Vanguard Group, Inc.

7.07%

Portolan Capital Management, L.L.C.

5.58%

Principal Global Investors (Equity)

5.08%

Dimensional Fund Advisors, L.P.

4.16%

Other

70.09%

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

8.01%

The Vanguard Group, Inc.

7.07%

Portolan Capital Management, L.L.C.

5.58%

Principal Global Investors (Equity)

5.08%

Dimensional Fund Advisors, L.P.

4.16%

Other

70.09%

股東類型

持股股東

佔比

Investment Advisor

37.18%

Investment Advisor/Hedge Fund

35.28%

Hedge Fund

15.91%

Individual Investor

2.91%

Research Firm

2.85%

Pension Fund

0.97%

Bank and Trust

0.48%

Venture Capital

0.07%

Corporation

0.05%

Other

4.30%

機構持股

更新時間: 7月1日週二

報告期間

機構數

持股數

持股佔比

持股變動

2025Q2

403

27.71M

95.98%

-3.07M

2025Q1

423

27.42M

95.08%

-3.59M

2024Q4

413

27.81M

97.60%

-2.39M

2024Q3

414

27.79M

100.23%

-3.05M

2024Q2

400

27.44M

99.43%

-4.42M

2024Q1

407

28.20M

102.27%

-5.76M

2023Q4

407

26.80M

99.62%

-6.63M

2023Q3

416

26.10M

97.38%

-6.68M

2023Q2

414

24.88M

93.24%

-6.39M

2023Q1

420

24.03M

90.08%

-9.68M

股東持股明細

名稱

持股數

佔比

持股變動

變動比例

公告日期

BlackRock Institutional Trust Company, N.A.

2.31M

8.01%

+53.08K

+2.35%

Mar 31, 2025

The Vanguard Group, Inc.

2.04M

7.07%

+215.03K

+11.77%

Mar 31, 2025

Portolan Capital Management, L.L.C.

1.61M

5.58%

+345.88K

+27.34%

Apr 07, 2025

Principal Global Investors (Equity)

1.47M

5.08%

+32.21K

+2.24%

Mar 31, 2025

Dimensional Fund Advisors, L.P.

1.20M

4.16%

+200.76K

+20.09%

Mar 31, 2025

Wasatch Global Investors Inc

998.46K

3.46%

-797.63K

-44.41%

Mar 31, 2025

Wellington Management Company, LLP

828.53K

2.87%

+106.41K

+14.74%

Mar 31, 2025

Nuveen LLC

723.60K

2.51%

+369.89K

+104.57%

Mar 31, 2025

State Street Global Advisors (US)

715.03K

2.48%

+4.82K

+0.68%

Mar 31, 2025

Renaissance Technologies LLC

701.20K

2.43%

+16.20K

+2.36%

Mar 31, 2025

持股ETF

更新時間: 8月2日週六

機構名稱

佔比

SPDR S&P Health Care Services ETF

1.13%

Harbor Human Capital Factor US Small Cap ETF

0.27%

Royce Quant Small-Cap Quality Value ETF

0.25%

Inspire Small/Mid Cap ESG ETF

0.2%

iShares Micro-Cap ETF

0.13%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

0.11%

iShares U.S. Healthcare Providers ETF

0.09%

Avantis US Small Cap Equity ETF

0.07%

Invesco Nasdaq Biotechnology ETF

0.07%

Goldman Sachs Innovate Equity ETF

0.07%

SPDR S&P Health Care Services ETF

佔比1.13%

Harbor Human Capital Factor US Small Cap ETF

佔比0.27%

Royce Quant Small-Cap Quality Value ETF

佔比0.25%

Inspire Small/Mid Cap ESG ETF

佔比0.2%

iShares Micro-Cap ETF

佔比0.13%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

佔比0.11%

iShares U.S. Healthcare Providers ETF

佔比0.09%

Avantis US Small Cap Equity ETF

佔比0.07%

Invesco Nasdaq Biotechnology ETF

佔比0.07%

Goldman Sachs Innovate Equity ETF

佔比0.07%

分紅派息

近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股

公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

KeyAI

